The market making agreement with Norne Securities has been cancelled, effective from 10 July 2014.


Oslo, 10 July 2014
CellCura ASA
Tore Viana-Rønningen
Chief Executive Officer
Phone: + 47 911 08 693

CellCura ASA is dedicated to the development and sales of cell technologies for use in assisted reproductive technology (ART) and stem cell research worldwide, representing improved safety and efficiency compared to traditional technology. CellCura is listed on the Oslo Axess market at the Oslo Stock Exchange (ticker: CELL).


www.cellcura.com


This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

distributed by